Jon T. Einarsson

Lund, M, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project.

Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project.

Journal: Annals of the rheumatic diseases

Published: February 19, 2026

Synovial fluid potentiates local fibroblasts to drive monocyte activation in juvenile idiopathic arthritis.

Synovial fluid potentiates local fibroblasts to drive monocyte activation in juvenile idiopathic arthritis.

Journal: Arthritis research & therapy

Published: December 11, 2025

Impaired cellular immune responses to herpes zoster subunit vaccine in patients with rheumatoid arthritis receiving Janus kinase inhibitors.

Impaired cellular immune responses to herpes zoster subunit vaccine in patients with rheumatoid arthritis receiving Janus kinase inhibitors.

Journal: Rheumatology (Oxford, England)

Published: June 27, 2025

Prevalence and Predictors of Achieving Sustained Remission in Psoriatic Arthritis: A Swedish Nationwide Registry Study.

Prevalence and Predictors of Achieving Sustained Remission in Psoriatic Arthritis: A Swedish Nationwide Registry Study.

Journal: The Journal of rheumatology

Published: April 22, 2025

Lifestyle discussions facilitate self-management in RA: a qualitative study of patients' perceptions.

Lifestyle discussions facilitate self-management in RA: a qualitative study of patients' perceptions.

Journal: BMC rheumatology

Published: August 23, 2024

Predictors at diagnosis for start of biologic disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis: a cohort study.

Predictors at diagnosis for start of biologic disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis: a cohort study.

Journal: BMJ open

Published: February 21, 2024

Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis: what is the role of inflammation control?

Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis: what is the role of inflammation control?

Journal: Scandinavian journal of rheumatology

Published: November 30, 2023

Serologic immunogenicity and safety of herpes zoster subunit vaccine in patients with rheumatoid arthritis receiving Janus kinase inhibitors.

Serologic immunogenicity and safety of herpes zoster subunit vaccine in patients with rheumatoid arthritis receiving Janus kinase inhibitors.

Journal: Rheumatology (Oxford, England)

Published: August 16, 2023

Sustained Remission in Patients With Rheumatoid Arthritis Receiving Triple Therapy Compared to Biologic Therapy: A Swedish Nationwide Register Study.

Sustained Remission in Patients With Rheumatoid Arthritis Receiving Triple Therapy Compared to Biologic Therapy: A Swedish Nationwide Register Study.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: April 24, 2020

Secular trends of sustained remission in rheumatoid arthritis, a nationwide study in Sweden.

Secular trends of sustained remission in rheumatoid arthritis, a nationwide study in Sweden.

Journal: Rheumatology (Oxford, England)

Published: January 13, 2019

Prevalence of sustained remission in rheumatoid arthritis: impact of criteria sets and disease duration, a Nationwide Study in Sweden.

Prevalence of sustained remission in rheumatoid arthritis: impact of criteria sets and disease duration, a Nationwide Study in Sweden.

Journal: Rheumatology (Oxford, England)

Published: September 30, 2017

Rituximab in clinical practice: dosage, drug adherence, Ig levels, infections, and drug antibodies.

Rituximab in clinical practice: dosage, drug adherence, Ig levels, infections, and drug antibodies.

Journal: Clinical rheumatology

Published: February 03, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026